Blue Sky Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Blue Sky Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-11,816	Closed	-$1.29M	–	122
2017 Q1	$1.29M	Buy	+11,816	New	+$1.04M	0.77%	18

Other funds holding VRTX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Blue Sky Asset Management's VRTX Position: Q2 2017 in Review

Blue Sky Asset Management sold out of Vertex Pharmaceuticals (VRTX) in Q2 2017, closing a stake of 11,816 shares — an estimated $1.29M sold.

Blue Sky Asset Management first reported a position in VRTX in Q1 2017 and held it in 1 quarter. The position peaked at $1.29M in Q1 2017. 582 funds tracked by Wall St. Rank hold VRTX as of Q2 2017.

Blue Sky Asset Management reported no remaining Vertex Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
Blue Sky Asset Management sold 11,816 Vertex Pharmaceuticals shares in Q2 2017, an estimated $1.29M.
Blue Sky Asset Management first reported a position in Vertex Pharmaceuticals in Q1 2017 and held it in 1 quarter.
Blue Sky Asset Management's Vertex Pharmaceuticals position peaked at $1.29M in Q1 2017.
582 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2017.

Based on Blue Sky Asset Management's 13F filing for Q2 2017, filed 1 Aug 2017.